共 238 条
[1]
Jamdade VS(2015)Therapeutic targets of triple-negative breast cancer: a review Br J Pharmacol 172 4228-4237
[2]
Sethi N(2016)Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease Nat Rev Clin Oncol 13 674-690
[3]
Mundhe NA(2009)Clinical features and course of brain metastases in triple-negative breast cancer: Comparison with HER2+ and other type J Clin Oncol 27 1064-931
[4]
Kumar P(2011)Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses’ Health Study Mod Pathol 24 924-348
[5]
Lahkar M(2013)Expression of androgen receptors in triple negative breast carcinomas Acta Histochem 115 344-368
[6]
Sinha N(2014)Androgen receptor (AR) expression in 400 breast carcinomas: is routine AR assessment justified? Am J Cancer Res 4 353-367
[7]
Bianchini G(2014)Androgen receptor-positive triple negative breast cancer: a unique breast cancer subtype Ann Surg Oncol 21 361-189
[8]
Balko JM(2015)Androgen receptor and enzymes in lymph node metastasis and cancer reoccurrence in triple-negative breast cancer Int J Biol Markers 30 e184-516
[9]
Mayer IA(2012)Decreased androgen receptor expression is associated with distant metastases in patients with androgen receptor-expressing triple-negative breast carcinoma Am J Clin Pathol 138 511-46491
[10]
Sanders ME(2016)Prognostic value of androgen receptor in triple negative breast cancer: A meta-analysis Oncotarget 7 46482-332